1. Home
  2. XRTX vs OMH Comparison

XRTX vs OMH Comparison

Compare XRTX & OMH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo XORTX Therapeutics Inc.

XRTX

XORTX Therapeutics Inc.

HOLD

Current Price

$0.97

Market Cap

3.9M

Sector

Health Care

ML Signal

HOLD

Logo Ohmyhome Limited

OMH

Ohmyhome Limited

HOLD

Current Price

$3.08

Market Cap

4.6M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
XRTX
OMH
Founded
2011
2015
Country
Canada
Singapore
Employees
N/A
N/A
Industry
Pharmaceuticals and Biotechnology
Real Estate
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
3.9M
4.6M
IPO Year
2018
2022

Fundamental Metrics

Financial Performance
Metric
XRTX
OMH
Price
$0.97
$3.08
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
★ 346.0K
76.0K
Earning Date
11-16-2026
11-27-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$39.14
Revenue Next Year
$392.31
$145.74
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.35
$0.06
52 Week High
$3.60
$3.75

Technical Indicators

Market Signals
Indicator
XRTX
OMH
Relative Strength Index (RSI) 28.81 66.61
Support Level $0.37 $2.17
Resistance Level $2.26 $3.75
Average True Range (ATR) 0.22 0.31
MACD -0.07 0.02
Stochastic Oscillator 2.73 62.70

Price Performance

Historical Comparison
XRTX
OMH

About XRTX XORTX Therapeutics Inc.

XORTX Therapeutics Inc is a clinical-stage pharmaceutical company focused on developing therapies to treat gout and progressive kidney disease modulated by aberrant purine and uric acid metabolism in orphan disease indications such as allopurinol-intolerant gout and autosomal dominant polycystic kidney disease, as well as more prevalent type 2 diabetic nephropathy and fatty liver disease. Its focus is on developing products to slow and/or reverse the progression of these diseases. The Company operates in one reportable operating segment: the development and commercialization of therapies to treat hyperuricemia-related diseases.

About OMH Ohmyhome Limited

Ohmyhome Ltd is a data and technology-driven property technology company based in Singapore. Through its subsidiaries, it operates a one-stop-shop property platform that provides end-to-end property solutions and services for its customers, which comprises brokerage services and emerging and other services, such as home renovation and furnishing services, listing and research, mortgage referral, legal services, and insurance referral services. The company derives its revenues from two sources: revenue from brokerage services, property management services, Digital Marketing Services, and emerging and other services. The firm operates in two segments, which are Brokerage, emerging and another related service; and Estate management services and other related services in Singapore.

Share on Social Networks: